About SH3 and cysteine-rich domain-containing protein
SH3 and cysteine-rich domain-containing protein (STAC) is a protein
from Homo sapiens identified by UniProt accession
Q99469, 402 residues long.
MolForge cross-references it against 0 known binders and
28 disease associations.
Target properties
| Protein name | SH3 and cysteine-rich domain-containing protein |
| UniProt accession | Q99469 |
| Gene | STAC |
| Organism | Homo sapiens |
| Length | 402 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (28)
Diseases linked to this target (Open Targets).
- hemoglobin measurement · score 0.35
- response to placebo · score 0.26
- adverse effect · score 0.09
- Hypoglycemia · score 0.09
- psychotic symptom measurement · score 0.06
- PHF-tau measurement · score 0.06
- Myalgia · score 0.05
- red blood cell density measurement · score 0.04
- non-small cell lung carcinoma · score 0.03
- protein measurement · score 0.02
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q99469-F1 | alphafold | PREDICTED | 65.89 | — |
Amino-acid sequence (402 residues)
MIPPSSPRED GVDGLPKEAV GAEQPPSPAS TSSQESKLQK LKRSLSFKTK SLRSKSADNF FQRTNSEDMK LQAHMVAEIS PSSSPLPAPG SLTSTPARAG LHPGGKAHAF QEYIFKKPTF CDVCNHMIVG TNAKHGLRCK ACKMSIHHKC TDGLAPQRCM GKLPKGFRRY YSSPLLIHEQ FGCIKEVMPI ACGNKVDPVY ETLRFGTSLA QRTKKGSSGS GSDSPHRTST SDLVEVPEEA NGPGGGYDLR KRSNSVFTYP ENGTDDFRDP AKNINHQGSL SKDPLQMNTY VALYKFVPQE NEDLEMRPGD IITLLEDSNE DWWKGKIQDR IGFFPANFVQ RLQQNEKIFR CVRTFIGCKE QGQITLKENQ ICVSSEEEQD GFIRVLSGKK KGLIPLDVLE NI
Explore SH3 and cysteine-rich domain-containing protein with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets